D59.12 Cold autoimmune hemolytic anemia
The ICD-10-CM code for Cold autoimmune hemolytic anemia is D59.12 (FY2026). It is a billable, claim-ready diagnosis code.
Classification
- Section
- D55-D59: Hemolytic anemias (D55-D59)
- Category D59
- 19 codes (16 billable)
- FY2026 Status
- Stable since FY2024
Also Known As
ICD-10-CM Alphabetic Index entries that lead to D59.12:
- Cold › agglutinin disease or hemoglobinuria (chronic)
- Sensitive, sensitivity › cold, autoimmune
- Cold › sensitivity, auto-immune
- Disease, diseased › cold › agglutinin or hemoglobinuria
- Hemoglobinuria › cold (paroxysmal) (with Raynaud's syndrome) › agglutinin
- Disease, diseased › cold › hemagglutinin (chronic)
- Anemia (essential) (general) (hemoglobin deficiency) (infantile) (primary) (profound) › hemolytic › cold type (primary) (secondary) (symptomatic)
- Anemia (essential) (general) (hemoglobin deficiency) (infantile) (primary) (profound) › hemolytic › autoimmune › cold
Inclusion Terms
- Chronic cold hemagglutinin disease
- Cold agglutinin disease
- Cold agglutinin hemoglobinuria
- Cold type (primary) (secondary) (symptomatic) autoimmune hemolytic anemia
- Cold type autoimmune hemolytic disease
U.S. Hospital Utilization
- An estimated 3,235 U.S. inpatient stays in 2023 included D59.12 among the documented diagnoses.
- 770 stays listed it as the principal diagnosis.
Source: National Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, 2016–2023. National survey-weighted estimates.
Official Coding Guidelines
Chapter 3 TOC entry3. Chapter 3: Disease of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89) ............................................................................................. 39
Reserved for future guideline expansionReserved for future guideline expansion ...................................................................................... 39
Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026